Mysoline (Primidone)

Primidone is used in the management of seizure disorders within the epilepsy spectrum.

• Partial seizures: reduces the frequency and severity of focal seizure episodes.
• Generalized tonic‑clonic seizures: helps control convulsive episodes across the population.
• Epilepsy (overall): provides long‑term seizure control as part of an antiepileptic regimen.

• Primidone is metabolized in the liver to phenobarbital, which enhances gamma‑aminobutyric acid (GABA)‑mediated neuronal inhibition. By increasing GABA activity, it stabilises neuronal membranes and raises the seizure threshold, thereby reducing the likelihood of abnormal electrical discharges in the brain.

Primidone may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Drowsiness: feeling unusually sleepy or fatigued.
• Dizziness: sensation of light‑headedness or unsteadiness.
• Nausea: upset stomach or urge to vomit.
• Ataxia: impaired coordination and balance.
• Rash: mild skin irritation or redness.
• Weight gain: increase in body weight over time.

Serious or Rare Side Effects

• Severe skin reactions: such as Stevens‑Johnson syndrome.
• Blood dyscrasias: including agranulocytosis or aplastic anemia.
• Hepatic dysfunction: signs of liver injury or elevated enzymes.
• Respiratory depression: slowed breathing, especially with other depressants.
• Suicidal ideation: emergence of thoughts of self‑harm.
• Withdrawal seizures: occurring after abrupt discontinuation.

When prescribing or dispensing Primidone, several safety considerations are important.

• Monitor blood counts: regular laboratory testing to detect hematologic abnormalities.
• Avoid abrupt discontinuation: taper the dose gradually to prevent withdrawal seizures.
• Use caution in hepatic impairment: dose adjustments may be required for liver disease.
• Pregnancy: consult a healthcare professional; risks and benefits must be weighed.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Primidone can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

• Phenobarbital: additive CNS depression and increased toxicity.
• Other central nervous system depressants (e.g., benzodiazepines, opioids): heightened sedative effects.
• Alcohol: potentiates drowsiness and respiratory depression.

Moderate Interactions (Monitor Closely)

• Valproic acid: may alter plasma levels of both agents.
• Carbamazepine: can increase metabolism of Primidone, reducing effectiveness.
• Oral contraceptives: Primidone may reduce hormonal contraceptive efficacy, requiring additional contraception methods.